Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.862 SEK | +0.98% | -9.39% | +5.08% |
Apr. 29 | Transcript : Immunovia AB, Q1 2024 Earnings Call, Apr 29, 2024 | |
Apr. 29 | Immunovia Streamlines Lab Operations with Move to Research Triangle Park, North Carolina | CI |
Business Summary
Number of employees: 11
Sales per Business
SEK in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Non-invasive Blood Tests
100.0
%
| 1 | 100.0 % | 1 | 100.0 % | +35.66% |
Sales per region
SEK in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Sweden
59.1
%
| 1 | 59.2 % | 1 | 59.1 % | +35.40% |
United States
40.9
%
| 0 | 0.0 % | 0 | 40.9 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Jeff Borcherding
CEO | Chief Executive Officer | - | - |
Director of Finance/CFO | 62 | 22-03-31 | |
Karl Stone
COO | Chief Operating Officer | 61 | 23-02-28 |
Chief Tech/Sci/R&D Officer | - | 23-01-31 | |
Linda Mellby
CTO | Chief Tech/Sci/R&D Officer | - | - |
Thomas C. King
CTO | Chief Tech/Sci/R&D Officer | 66 | 16-12-31 |
Chief Tech/Sci/R&D Officer | 71 | 12-12-31 | |
Philipp Mathieu
BRD | Director/Board Member | 46 | 22-01-19 |
Tobias Bülow
IRC | Investor Relations Contact | - | 22-01-14 |
Cindy Callahan
SAM | Sales & Marketing | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 70 | 16-12-08 | |
Peter Andersen
CHM | Chairman | 67 | 19-12-31 |
Michael Löfman
BRD | Director/Board Member | - | 23-05-21 |
Martin Møller
BRD | Director/Board Member | 49 | 20-12-31 |
Eric Krafft
BRD | Director/Board Member | 49 | 22-03-31 |
Philipp Mathieu
BRD | Director/Board Member | 46 | 22-01-19 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 45,287,498 | 34,200,305 ( 75.52 %) | 0 | 75.52 % |
Company contact information
Sector
Sales per region
1st Jan change | Capi. | |
---|---|---|
+5.08% | 7.81M | |
-14.68% | 18.88B | |
-42.33% | 2.84B | |
+17.00% | 1.85B | |
-0.51% | 1.66B | |
+27.15% | 1.26B | |
-13.90% | 989M | |
-21.76% | 896M | |
-2.72% | 757M | |
-23.95% | 637M |
- Stock Market
- Equities
- IMMNOV Stock
- Company Immunovia AB